BIOMAT Database Logo BIOMAT Database Logo

The angiotensin infusion test: preliminary experience. 1966

N W Swinton

UI MeSH Term Description Entries
D006977 Hypertension, Renal Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN. Hypertensions, Renal,Renal Hypertension,Renal Hypertensions
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012078 Renal Artery Obstruction Narrowing or occlusion of the RENAL ARTERY or arteries. It is due usually to ATHEROSCLEROSIS; FIBROMUSCULAR DYSPLASIA; THROMBOSIS; EMBOLISM, or external pressure. The reduced renal perfusion can lead to renovascular hypertension (HYPERTENSION, RENOVASCULAR). Renal Artery Stenosis,Obstruction, Renal Artery,Obstructions, Renal Artery,Renal Artery Obstructions,Renal Artery Stenoses,Stenoses, Renal Artery,Stenosis, Renal Artery
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000792 Angiography Radiography of blood vessels after injection of a contrast medium. Arteriography,Angiogram,Angiograms,Angiographies,Arteriographies
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

N W Swinton
The angiotensin infusion test.
August 1966, The Journal of urology,
N W Swinton
The angiotensin-infusion test.
January 1966, Lancet (London, England),
N W Swinton
Angiotensin infusion test.
January 1968, Canadian Medical Association journal,
N W Swinton
ANGIOTENSIN-INFUSION TEST.
July 1965, Lancet (London, England),
N W Swinton
Angiotensin infusion test.
November 1965, Lancet (London, England),
N W Swinton
Angiotensin infusion test in hypertension.
May 1966, American heart journal,
N W Swinton
[Angiotensin II analogue infusion test].
April 1997, Nihon rinsho. Japanese journal of clinical medicine,
N W Swinton
THE ANGIOTENSIN INFUSION TEST FOR RENOVASCULAR HYPERTENSION.
March 1965, Connecticut medicine,
N W Swinton
[Diagnostic significance of the angiotensin infusion test].
October 1968, Revista medica de Chile,
N W Swinton
[Angiotensin infusion test in liver cirrhosis].
January 1971, Polskie Archiwum Medycyny Wewnetrznej,
Copied contents to your clipboard!